SENSEX NIFTY

Glaxosmithkline

Oct 22, 2014 at 08:28 | Source: CNBC
Investors have been increasingly willing to dip into stocks with no new negative developments in Ebola, a steadying of oil prices, and the sense that the Federal Reserve will not move to raise rates quickly even as it ends bond buying.
Oct 16, 2014 at 08:16 | Source: CNBC-TV18
Tata Steel | Bajaj Auto | Tata Motors | NTPC | Future Retail | IOC | Reliance Infrastructure | GVK Power | Mindtree | GSFC | Gruh Finance | Cyient | NIIT Technologies | Blue Dart | Bajaj Holdings | Gujarat Alkalies | Essar Oil | Persistent Systems | Lupin and Sadbhav Engineering are stocks, which are in the news today.
Oct 14, 2014 at 17:37 | Source: PTI
Penalties, totalling to Rs 25 lakh which needs to be paid within 45 days, have been imposed by the capital market regulator for violating various provisions of Sebi's Takeover Regulations.
Oct 11, 2014 at 14:53 | Source: Moneycontrol.com
Analysts at Motilal Oswal believe that Lupin, Ranbaxy, Cadila Healthcare, GSK Pharma, Torrent Pharma and Alembic Pharma will report stronger overall operational performance during this quarter.
Oct 09, 2014 at 16:14 | Source: Moneycontrol.com
GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 06, 2014, inter alia, to consider & approval of unaudited financial results for the quarter ended September 30, 2014 (Q3).
Sep 30, 2014 at 11:45 | Source: Moneycontrol.com
Brokerage house Firstcall Research is bullish on GlaxoSmithKline Consumer Healthcare and has recommended buy rating on the stock with a target price of Rs 5815 in its research report dated September 25, 2014.
Sep 17, 2014 at 13:17 | Source: CNBC-TV18
Here are few top buzzing stocks picked by CNBC-TV18's analysts in trade today. We have NCC, Zee Entertainment, Hero MotoCorp, Bajaj Auto, IRB Infrastructure, Biocon, Dr. Reddy and GSK Pharma.
Sep 17, 2014 at 13:11 | Source: CNBC-TV18
The DRL-GSK deal was to sell branded generic formulations in emerging markets and was entered into in 2009.
Sep 17, 2014 at 13:01 | Source: CNBC-TV18
Praful Bohra of Nirmal Bang Institutional Equities feels Lupins deal with Merck Serano will help the former to make way into incremental markets. Further, he has a positive call on the stock, as he believes recent initiatives taken by the pharma major will be beneficial for business in medium term.
Sep 16, 2014 at 09:57 | Source: CNBC-TV18
Neelkanth Mishra, Credit Suisse says consumption remains a secular growth story in India with years of catch up to even other emerging markets.
Messages on Glaxosmithkline »

arinshare

Gold Member

6 Followers

MF Investment Help  

Dear Soporofic, I take fancy of two stocks - GlaxoSmithKline Pharmaceuticals and GlaxoSmithKline Consumer Healthcare. Please share your stand on its future prospects. Another point I like to know how do you buy or pick stock right now at this life time high market? What is your conviction

4.08 PM Jul 6th

Web Messenger

Platinum Member

245750 Followers

GlaxoSmithKline  

Source:BBC - Allegations that pharmaceutical giant GlaxoSmithKline (GSK) systematically bribed doctors in China are credible, says an investigator hired by the firm. Peter Humphrey was hired only to investigate who was behind a suspected smear campaign against GSK. But after he finished his report

3.50 PM Jul 4th

Web Messenger

Platinum Member

245750 Followers

GlaxoSmithKline  

Source:BBC - To observers of China`s contemporary business culture it will come as no great surprise that the latest twist in GlaxoSmithKline`s China crisis is a sex tape. The secret filming of business, political and love rivals in intimate situations is now commonplace in China and motivations

3.50 PM Jul 4th

Expert Chartist

Platinum Member

10034 Followers

GlaxoSmithKline  

At 12:00 hrs GlaxoSmithKline has formed a bearish bar reversal chart pattern today. A Bearish Bar Reversal occurs when today\'s high is higher than its previous day high and the current price / today\'s close is lower than its previous day close.

12.00 PM Jul 4th

Omar_An

Silver Member

0 Follower

GlaxoSmithKline  

USA-based Isis Pharmaceuticals has earned yet another $1 million payment from UK pharma giant GlaxoSmithKline.

11.09 AM Jul 4th

PipaDove

New Member

0 Follower

GlaxoSmithKline  

3000 just round the corner. Buy and wait! - My target for GlaxoSmithKline is Rs 3000 for the short term with a stoploss of Rs 2545

10.42 AM Jul 4th

BSE/NSE Announcer

Platinum Member

4703 Followers

GlaxoSmith Con  

GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that in accordance with the Companys Policy on Insider Trading, the date of commencement of closing of "Trading Window" shall be from July 03, 2014 and shall end 24 hours after public announcement of the Quarterly Financial Result

5.40 PM Jul 2nd

GlaxoSmithKline  

GlaxoSmithKline is a Sell - My target for GlaxoSmithKline is Rs 25120 for the short term with a stoploss of Rs 560

2.47 PM Jun 30th

Market Statistician

Platinum Member

10441 Followers

GlaxoSmithKline  

GlaxoSmithKline Pharmaceuticals has touched a 52-week low of Rs 2,351.60. At 15:13 hrs, the share was quoting at Rs 2,466.00, down Rs 9.55, or 0.39%. See more

3.15 PM Jun 26th

Market Statistician

Platinum Member

10441 Followers

GlaxoSmithKline  

GlaxoSmithKline Pharmaceuticals has touched a 52-week low of Rs 2,351.60. At 13:13 hrs, the share was quoting at Rs 2,460.10, down Rs 15.45, or 0.62%. See more

1.15 PM Jun 26th

News across the web »
Oct 25, 2014 at 01:30 | Source: FirstPost
Oct 24, 2014 at 23:30 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.